CKJ (@CKJsocial) / X

CKJ

3,625 posts

CKJ

@CKJsocial

Clinical Kidney Journal, an online open access journal of @ERAkidney published monthly by @OxfordJournals.

United Kingdom

Joined October 2015

CKJ
@CKJsocial
Aug 11, 2024
Aging and CKD: epidemiology, therapy, management, & the role of immunity The authors summarize the epidemiological characteristics of CKD in the aging population, discuss the immunological mechanisms in aging-related CKD & the process of therapy 🆓doi.org/10.1093/ckj/sf…
4.5K
CKJ
@CKJsocial
Aug 26, 2022
SGLT-2 inhibitors in nephrotic range proteinuria: emerging clinical evidence ➡️This is the first comprehensive review on the effectiveness of SGLT-2 inhibitors for the treatment of patients with nephrotic range albuminuria or proteinuria Read more here: 🔓bit.ly/3Arhv3o
CKJ
@CKJsocial
Sep 28, 2023
Additive effects of dapagliflozin and finerenone on albuminuria in non-diabetic CKD 🔓 doi.org/10.1093/ckj/sf… ➡️ The combination of finerenone and dapagliflozin was safe and significantly reduced albuminuria
27K
CKJ
@CKJsocial
Jul 4, 2024
Dapagliflozin treatment of patients with chronic kidney disease without diabetes across different albuminuria levels (OPTIMISE-CKD) doi.org/10.1093/ckj/sf…
27K
CKJ
@CKJsocial
Feb 10, 2021
📢 We are very happy to announce that the newly elected CKJ Editor-in-Chief is Maria José Soler Romeo. She will start her term as CKJ Editor-in-Chief in June 2022 and will serve the journal for 3 years. Congratulations! @PepaSolerR
CKJ
@CKJsocial
Feb 1, 2023
SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence 🔓bit.ly/3DxozOC 📸Postulated mechanisms for the beneficial effect of SGLT-2 inhibitors in patients with nephrotic-range proteinuria
16K
CKJ
@CKJsocial
Nov 17, 2023
Optimization of guideline-directed medical therapies in patients with diabetes and chronic kidney disease 🔓doi.org/10.1093/ckj/sf…
21K
CKJ
@CKJsocial
Apr 5, 2024
Dapagliflozin treatment of patients with CKD without diabetes across different albuminuria levels 🔓doi.org/10.1093/ckj/sf… 👉Dapagliflozin demonstrated similar kidney protection, cardiorenal & all-cause mortality risk across UACR levels
10K
CKJ
@CKJsocial
Jun 8, 2023
Hypomagnesemia: a potential underlooked cause of persistent vitamin D deficiency in CKD doi.org/10.1093/ckj/sf… 👉It is essential to ensure adequate levels of magnesium to obtain the optimal benefits of vitamin D supplementation in CKD patients
13K
CKJ
@CKJsocial
Jun 16, 2025
Loop Diuretics in Anuric Hemodialysis Patients for the Clearance of Protein-Bound Uremic Toxins doi.org/10.1093/ckj/sf…
11K